Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

DENTSPLY International Inc Add to portfolio

NAS:XRAY, Oct 16, 08:36 UTC

Latest NAS:XRAY News

Filter your feed

Apply Filter

Sunday, October 14


News

Better Buy: Align Technology Inc. vs. Dentsply Sirona Inc.

XRAY

Better Buy: Align Technology Inc. vs. Dentsply Sirona Inc. Keith Speights, The Motley FoolMotley FoolOctober 14, 2018, 10:37 AM GMT. Align Technology Inc.(NASDAQ: ALGN) is the leader in clear dental aligners and intraoral scanners used by dentists and orthodontists. Dentsply Sirona Inc.(NASDAQ: XRAY) is the largest global manufacturer of professional dental products, including medical instruments, dental implants, and orthodontic appliances. Although Align and Dentsply Sirona serve the same industry, their stocks have gone in different directions so far this year. The simple fact is that demand continues to grow rapidly for Align's Invisalign clear aligners and iTero intraoral scanners. And there are several reasons that's the case. Orthodontic patients like that Invisalign aligners are practically invisible -- a nice change from traditional metal-and-wire braces.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Friday, October 12


News

Head to Head Comparison: DENTSPLY SIRONA (NASDAQ:XRAY) vs. Remedent (REMI) – XNewsPress

XRAY

DENTSPLY SIRONA (NASDAQ:XRAY) and Remedent (OTCMKTS:REMI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings. This is a breakdown of recent recommendations and price targets for DENTSPLY SIRONA and Remedent, as reported by MarketBeat. DENTSPLY SIRONA presently has a consensus price target of $52.18, suggesting a potential upside of 45.60%.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Friday, September 14


News

DENTSPLY Launches Azento, Improves Digital Implant Workflow

XRAY

In a bid to revolutionize digital-implant workflow in dental care,DENTSPLY SIRONA Inc. XRAY recently launched a single tooth replacement solution — Azento — in the United States. It is a unique dental platform that will help dentists select the best-fitting implant, optimal implant positioning and feasible healing environment. A report by the Meticulous Research states that the global tooth replacement market is expected to reach $13,035.2 million by 2022, at a CAGR of 6.9%. The Azento launch is also a perfect example of the company’s strong R&D focus as it is made for patients and dental professionals.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Thursday, September 06


News

Dentsply (XRAY) Down 2.3% Since Last Earnings Report: Can It Rebound?

XRAY

A month has gone by since the last earnings report for Dentsply International (XRAY). Will the recent negative trend continue leading up to its next earnings release, or is Dentsply due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Net sales, excluding precious metal content, came in at $1.03 billion, up 5.1% year over year. For investors’ notice, DENTSPLY’s precious-metal dental alloy products, which are used by third parties to construct crown and bridge materials, are subject to certain risks of price fluctuations.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, August 14


News

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Dentsply Sirona, Inc. -- XRAY

XRAY

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Dentsply Sirona, Inc. -- XRAY. NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces it has commenced an investigation of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (XRAY) concerning possible violations of federal securities laws. On August 7, 2018, Dentsply reported that “During the quarter ended June 30, 2018, the Company recorded a goodwill and intangible impairment charge of $1,265 million.” Dentsply stated that the charge was largely the result of challenges in the Technologies and Equipment segment. To obtain additional information, go to:. or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Read Full Details

Topics:
  • Business
  • Financial

Monday, August 13


News

Here's Why You Should Dump DENTSPLY (XRAY) Stock Right Now - August 13, 2018

XRAY

Here's Why You Should Dump DENTSPLY (XRAY) Stock Right Now. Things have been very rough for DENTSPLY SIRONA Inc. XRAY of late, evident from a dismal guidance. The company is currently an underperformer in the competitive MedTech space. If you are still holding on to shares of this company, it is time you dump them, as chances of favorable returns in the near term are dim. In the last 60 days, the Zacks Consensus Estimate for DENTSPLY’s 2018 earnings per share (EPS) plunged 15.4% to $2.19. For the current quarter, the same for earnings is pegged at 51 cents.

Read Full Details

Topics:
  • Business
  • Financial

Friday, August 10


Social Chatter

Thursday, August 09


Social Chatter

DENTSPLY International Inc (NAS:XRAY) social chatter is higher than usual

XRAY
DENTSPLY SIRONA $XRAY Issues FY18 Earnings Guidance https://t.co/Ic3Zpsw1Pq #markets
Social Chatter

Wednesday, August 08


Social Chatter